ScoreHaematology

MASCC risk index for febrile neutropenia

Identifies patients with chemotherapy-induced febrile neutropenia at low risk of serious complications.

Updated 30 October 2026

When to use it

Adults with cancer and febrile neutropenia at fever onset, to consider oral or outpatient treatment.

What it needs

  • Burden of illness (overall state due to the episode)Options: No or mild symptoms · Moderate symptoms · Severe symptoms or moribund
  • No hypotension (SBP > 90 mmHg)Yes or no
  • No active COPDYes or no
  • Solid tumour, or haematological malignancy without previous fungal infectionYes or no
  • No dehydration requiring IV fluidsYes or no
  • Outpatient at fever onsetYes or no
  • Age < 60 yearsYes or no

The points for each answer and the automatic total are in the app.

How to interpret it

MASCC score
ResultInterpretation
≤ 20High risk of complications: admission and IV antibiotics
≥ 21Low risk: candidate for oral or outpatient treatment if other conditions are met

Practical tip

A score ≥ 21 defines low risk; the maximum score is 26.

3 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top